The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II study comparing mannitol with furosemide for the prevention of cisplatin-induced renal toxicity in advanced non-small cell lung cancer: The OLCSG1406 trial.
 
Go Makimoto
No Relationships to Disclose
 
Katsuyuki Hotta
Honoraria - AstraZeneca Japan; MSD; Nippon Kayaku; Nippon Kayaku
Research Funding - AstraZeneca Japan; Bristol-Myers Squibb; Chugai Pharma
 
Isao Oze
No Relationships to Disclose
 
Kiichiro Ninomiya
Honoraria - AstraZeneca; Lilly
 
Takashi Ninomiya
Honoraria - Chugai Pharma; Nippon Boehringer Ingelheim
Research Funding - Boehringer Ingelheim (Inst)
 
Toshio Kubo
Honoraria - AstraZeneca Japan; Bristol-Myers Squibb; Chugai Pharma; Kyowa Hakko Kirin; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Ono Pharmaceutical
 
Kadoaki Ohashi
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Ono Pharmaceutical
Research Funding - Boehringer Ingelheim; Lilly Japan; Novartis
 
Eiki Ichihara
No Relationships to Disclose
 
Kammei Rai
No Relationships to Disclose
 
Masahiro Tabata
No Relationships to Disclose
 
Yoshinobu Maeda
No Relationships to Disclose
 
Katsuyuki Kiura
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; MSD K.K; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - Boehringer Ingelheim; Ono Pharmaceutical
Other Relationship - Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical